Clinical Trials on Immune Checkpoint Inhibitors in Belgium

Total 1778 results

argenx
Iqvia Pty Ltd

Active, not recruiting

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome (Rho plus)

Primary Sjögren's Syndrome

Belgium, Hungary, Poland
Sanofi

Terminated

Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma (GRAAL2)

Hyperuricemia

Germany, Belgium, Italy, France
Hasselt University

Recruiting

Reliability and Validity of Outcome Measures for Pain in Multiple Sclerosis

Pain

Belgium, Chile, Italy
Jules Bordet Institute
Macopharma; Belgian Hematological Society

Recruiting

Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD)

Refractory Chronic Graft Versus Host Disease (cGVHD)

Belgium
Rob Gruters
Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Universitair Ziekenhuis... and other collaborators

Terminated

iHIVARNA Clinical Trial in HIV Infected Individuals (iHIVARNA-01)

HIV Infections

Netherlands, Spain, Belgium
The Lymphoma Academic Research Organisation
Novartis

Completed

A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma (HIJAK)

Hodgkin's Lymphoma

France, Belgium
Abivax S.A.

Completed

ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment

HIV Infection

Spain, Belgium, France
International AIDS Vaccine Initiative
Children's Hospital of Philadelphia; Nationwide Children's Hospital; Targeted...

Completed

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine (A001)

HIV Infection

Belgium, Germany, India
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study of Subcutaneous and Intravenous VELCADE in Patients With Previously Treated Multiple Myeloma

Multiple Myeloma

Belgium, France, Germany
University Ghent

Active, not recruiting

Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in Children

Cow Milk Allergy | Food Allergy

Belgium
Boehringer Ingelheim

Completed

To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL

Lymphoma, Large B-Cell, Diffuse

Spain, Italy, Belgium
Tibotec Pharmaceuticals, Ireland

Completed

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

HIV

United Kingdom, Germany, Denmark, Belgium, Austria, Poland, Australia, Russian Federation
Charite University, Berlin, Germany

Completed

Risk Stratified Sequential Treatment for CD20-positive PTLD (PTLD-1/3)

Posttransplant Lymphoproliferative Disorder | PTLD

Australia, France, Germany, Sweden, Belgium, Italy, Poland
Merck KGaA, Darmstadt, Germany

Completed

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | Advanced Solid Tumors

Belgium, Netherlands, Denmark
Wellspect HealthCare

Terminated

Efficacy of Clean Intermittent Catheterization (CIC) in Multiple Sclerosis (MS) Patients With Bladder Dysfunction

Multiple Sclerosis | Bladder Dysfunction

Belgium, Netherlands, Germany, United Kingdom
Universitaire Ziekenhuizen KU Leuven
Fonds voor Wetenschappelijk Reumaonderzoek (FWRO)

Recruiting

Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis (RITUXERA)

Rheumatoid Arthritis

Belgium
Lymphoma Study Association
Janssen-Cilag International NV

Completed

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma

France, Belgium
The Lymphoma Academic Research Organisation
Karyopharm Therapeutics Inc

Completed

A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP (SELINDA)

B-cell Lymphoma

Belgium, France
Galapagos NV
MorphoSys AG

Completed

First in Human of Single and Multiple Doses of MOR106

Healthy | Dermatitis, Atopic

Belgium, Hungary, Moldova, Republic of, Romania
KU Leuven

Not yet recruiting

The Use of a Monitoring Device by General Practitioners During Out-of-hours Care

Heart Failure | Pneumonia | Pneumothorax | Emergencies | Atrial Fibrillation | Asthma | Hyperventilation | Acute Coronary Syndrome | Cardiac Arrest | Atrial Flutter | Pulmonary Embolism | Acute Myocardial Infarction | Pulmonary Edema | Rhythm; Abnormal | Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Belgium
Biogen

Terminated

BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

Rheumatoid Arthritis

United States, Belgium, Canada, United Kingdom
Sanofi
Genzyme, a Sanofi Company

Completed

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Multiple Myeloma

Sweden, Estonia, Belgium, Lithuania
Dompé Farmaceutici S.p.A

Completed

A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes

Diabetes Mellitus, Insulin-Dependent

Germany, Belgium, Italy
P. Verschueren
Agentschap voor Innovatie door Wetenschap en Technologie

Completed

Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.

Rheumatoid Arthritis

Belgium
Association de Recherche Clinique en Rhumatologie
RCTs

Unknown

Sensitivity of Echography in Arthritis (SEA)

Rheumatoid Arthritis

Belgium, France
Pfizer

Terminated

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Healthy | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Primary Immune Thrombocytopenia

Spain, United States, Belgium, United Kingdom, New Zealand
Fundación Pública Andaluza Progreso y Salud
Karolinska Institutet; Eli Lilly and Company; Medical University of Vienna; Sanofi and other collaborators

Completed

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control (PRECISESADST)

Healthy Subjects

France, Austria, Germany, Portugal, Hungary, Belgium, Italy, Spain, Switzerland
Novartis

Terminated

Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis

Rheumatoid Arthritis

Germany, Belgium, Netherlands, Poland
Becton, Dickinson and Company

Terminated

An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Belgium
Commissie Voor Klinisch Toegepast Onderzoek
European Organisation for Research and Treatment of Cancer - EORTC

Unknown

Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma

Lymphoma

France, Netherlands, Belgium
Lymphoma Study Association
Fondation ARC

Completed

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

Lymphoma, Large-Cell, Diffuse

France, Belgium
Millennium Pharmaceuticals, Inc.

Completed

A Phase 1 Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

Hodgkin Lymphoma | Anaplastic Large-cell Lymphoma

Spain, Belgium, Lithuania
Smith & Nephew, Inc.
Smith & Nephew Orthopaedics AG

Terminated

Long Term Follow-up of Integra® Cadence™ Total Ankle System in Primary Ankle Joint Replacement

Rheumatoid Arthritis | Degenerative Arthritis | Traumatic Arthritis

Belgium, France, Canada, Spain, United Kingdom
Advancell - Advanced In Vitro Cell Technologies...
Nexus Oncology Ltd

Completed

Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients

Leukemia, B-Cell, Chronic

Spain, France, Belgium
Lymphoma Study Association

Completed

Randomized Study for Patients With Follicular Lymphoma Needing Treatment

Follicular Lymphoma

France, Belgium
Erasme University Hospital

Enrolling by invitation

Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes (INLOOP)

Diabetes Mellitus, Type 1

Belgium
University Hospital, Ghent

Recruiting

Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer (DART)

Prostate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Oligometastasis

Belgium
European Organisation for Research and Treatment...

Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Cancer

Belgium, Switzerland, Italy, France, Germany
St. Antonius Hospital
St. Antonius Research Fund

Recruiting

Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)

Aortic Valve Stenosis

Belgium, Netherlands
Stichting Hemato-Oncologie voor Volwassenen Nederland

Recruiting

REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)

CLL/SLL

Netherlands, Belgium, Denmark
Celyad Oncology SA

Active, not recruiting

Safety, Activity and Cell Kinetics of CYAD-211 in Patients With Relapsed or Refractory Multiple Myeloma (IMMUNICY-1)

Relapse/Refractory Multiple Myeloma

Belgium, United States
St Stephens Aids Trust

Completed

Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)

HIV

Germany, Spain, France, United Kingdom, Belgium, Italy
Medical University of Vienna

Completed

Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity (LUDOC II)

Ovarian Epithelial Cancer

Austria, Belgium, Czechia, Germany
Centre Hospitalier Universitaire Saint Pierre

Active, not recruiting

"Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"

HIV Infections | Yellow Fever Vaccine

Belgium
Ramsay Générale de Santé
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Molecular Diagnosis of Allergic Contact Dermatitis (SMECA). (SMECA)

Eczema | Allergic Contact Eczema Nos

France, Belgium
Technical University of Munich
Universitaire Ziekenhuizen KU Leuven; Helmholtz Zentrum München; Skane University... and other collaborators

Recruiting

Anti-viral Action Against Type 1 Diabetes Autoimmunity

Diabetes Mellitus, Type 1

Belgium, Germany, Sweden
Meyer Children's Hospital IRCCS

Active, not recruiting

Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.

Cytopenia

Italy, United States, Belgium
Hospital Clinic of Barcelona
Fundacion Clinic per a la Recerca Biomedica; Brighton and Sussex University... and other collaborators

Unknown

Validation Study of mHealth Technology in HIV to Improve Empowerment and Healthcare Utilisation: Research and Innovation to Generate Evidence for Personalised Care (EmERGE) (EMERGE)

HIV Infections

Spain, Belgium, Croatia, Portugal, United Kingdom
Fondazione Penta UK
UCL Great Ormond Street Institute of Child Health

Recruiting

Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)

HIV Infections

Spain, Switzerland, United Kingdom, Belgium, Italy, Romania, Russian Federation
Mologen AG

Completed

Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC (IMPULSE)

Small Cell Lung Cancer

Belgium, Spain, Austria, Germany

Clinical Trials on Immune Checkpoint Inhibitors in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations